These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22321551)

  • 1. [Expression of Sox11 transcription factor in different types of B-cell lymphomas].
    Zhang WM; Wang C; Li BZ
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):698-9. PubMed ID: 22321551
    [No Abstract]   [Full Text] [Related]  

  • 2. The expression of Bcl-2 by proliferating cells varies in different categories of B-cell lymphoma.
    Masir N; Jones M; Lee AM; Goff LK; Clear AJ; Lister A; Marafioti T; Mason DY
    Histopathology; 2010 Apr; 56(5):617-26. PubMed ID: 20459572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyclonal antibody targeting SOX11 cannot differentiate mantle cell lymphoma from B-cell non-Hodgkin lymphomas.
    Zhang LN; Cao X; Lu TX; Fan L; Wang L; Xu J; Zhang R; Zou ZJ; Wu JZ; Li JY; Xu W
    Am J Clin Pathol; 2013 Dec; 140(6):795-800. PubMed ID: 24225745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas.
    Krenacs L; Himmelmann AW; Quintanilla-Martinez L; Fest T; Riva A; Wellmann A; Bagdi E; Kehrl JH; Jaffe ES; Raffeld M
    Blood; 1998 Aug; 92(4):1308-16. PubMed ID: 9694719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunohistochemical patterns of follicular dendritic cell meshwork and Ki-67 in small B-cell lymphomas].
    Shi YF; Li XH
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):222-6. PubMed ID: 23928527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases.
    Cao X; Fan L; Fang C; Zhu DX; Dong HJ; Wang DM; Wang YH; Xu W; Li JY
    Med Oncol; 2012 Jun; 29(2):1190-6. PubMed ID: 21479697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma.
    Dictor M; Ek S; Sundberg M; Warenholt J; György C; Sernbo S; Gustavsson E; Abu-Alsoud W; Wadström T; Borrebaeck C
    Haematologica; 2009 Nov; 94(11):1563-8. PubMed ID: 19880779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic utility of SOX11 immunohistochemistry in differentiating cutaneous spread of mantle cell lymphoma from primary cutaneous B-cell lymphomas.
    Hsi AC; Hurley MY; Lee SJ; Rosman IS; Pang X; Gru A; Schaffer A
    J Cutan Pathol; 2016 Apr; 43(4):354-61. PubMed ID: 26762898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian non-Hodgkin's lymphoma: a clinicopathologic study of eight primary cases.
    Vang R; Medeiros LJ; Warnke RA; Higgins JP; Deavers MT
    Mod Pathol; 2001 Nov; 14(11):1093-9. PubMed ID: 11706069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1 expression in B-cell lymphomas.
    Gladkikh A; Potashnikova D; Korneva E; Khudoleeva O; Vorobjev I
    Exp Hematol; 2010 Nov; 38(11):1047-57. PubMed ID: 20727381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric analysis of SOX11: a new diagnostic method for distinguishing B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma from mantle cell lymphoma.
    Wasik AM; Priebe V; Lord M; Jeppsson-Ahlberg Å; Christensson B; Sander B
    Leuk Lymphoma; 2015 May; 56(5):1425-31. PubMed ID: 25120048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas.
    Tandon B; Peterson L; Gao J; Nelson B; Ma S; Rosen S; Chen YH
    Mod Pathol; 2011 Nov; 24(11):1433-43. PubMed ID: 21685909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histologic evaluation of malignant lymphoma].
    Li XQ
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):217-9. PubMed ID: 21615993
    [No Abstract]   [Full Text] [Related]  

  • 14. Long Non-Coding RNAs Guide the Fine-Tuning of Gene Regulation in B-Cell Development and Malignancy.
    Dahl M; Kristensen LS; Grønbæk K
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30134619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of SOX11 immunostaining in confirming the diagnosis of mantle cell lymphoma on fine-needle aspiration samples.
    Zhang YH; Liu J; Dawlett M; Guo M; Sun X; Gong Y
    Cancer Cytopathol; 2014 Dec; 122(12):892-7. PubMed ID: 25056830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
    Myklebust JH; Brody J; Kohrt HE; Kolstad A; Czerwinski DK; Wälchli S; Green MR; Trøen G; Liestøl K; Beiske K; Houot R; Delabie J; Alizadeh AA; Irish JM; Levy R
    Blood; 2017 Feb; 129(6):759-770. PubMed ID: 28011673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCL-6 protein is expressed in germinal-center B cells.
    Cattoretti G; Chang CC; Cechova K; Zhang J; Ye BH; Falini B; Louie DC; Offit K; Chaganti RS; Dalla-Favera R
    Blood; 1995 Jul; 86(1):45-53. PubMed ID: 7795255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive B-cell lymphomas.
    Yang W; Listinsky CM
    Adv Exp Med Biol; 2005; 563():125-34. PubMed ID: 16433128
    [No Abstract]   [Full Text] [Related]  

  • 19. [Application of gene expression profiling in molecular classification, prognosis and therapy of B-cell lymphoma].
    Mao ZR; Zhou R; Zhang XX; Mueller-Hermelink Hk; Rosenwald A
    Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):785-9. PubMed ID: 20079025
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of Myc target gene mina53 in subtypes of human lymphoma.
    Teye K; Arima N; Nakamura Y; Sakamoto K; Sueoka E; Kimura H; Tsuneoka M
    Oncol Rep; 2007 Oct; 18(4):841-8. PubMed ID: 17786344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.